Meningitis B Vaccine Offered to UK Students and School Leavers

The UK is rolling out a meningitis B vaccination program for young adults, targeting students and school leavers to prevent outbreaks.

The UK is set to offer the meningitis B (MenB) vaccine to approximately one million young people, including those completing their final year of school and those starting university in autumn 2026. This initiative comes in response to recent clusters of MenB cases, highlighting the increased risk among young adults in shared living environments.

The decision follows tragic incidents, including the death of Aaron Millsan 18-year-old student from Kidderminster, Worcestershire, who passed away from meningitis in. His family’s devastating experience underscores the urgent need for expanded vaccination efforts.

The Urgency Behind the Vaccination Drive

Health officials have identified a heightened risk of meningitis B among 18-year-olds and university students due to increased social mixing and shared accommodation. The UK Health Security Agency (UKHSA) reported three unusual clusters of MenB disease, including an unprecedented outbreak in Kent with 21 cases and two deaths in.

Additional clusters were noted in Weymouth and Reading, further emphasizing the need for preventive measures.

Prof Shamez Ladhani of the UKHSA explained that the UK has experienced a honeymoon period of low MenB activity over the past 25 years, potentially leaving populations more susceptible to the disease. The Bexsero vaccine, already routinely given to infants, offers protection for at least six years and has shown a 75% reduction in MenB cases among vaccinated infants.

Implementation and Eligibility

The one-off vaccination program will be available to most pupils completing Year 13 or equivalent in the summer of 2026, as well as young people aged 18-25 starting university or residential further education for the first time in autumn 2026. Two doses of the vaccine are required, administered at least 28 days apart.

In England, vaccinations will be offered through community pharmacies in July and August, with eligible individuals contacted via the NHS app, text, email, or letter. Under-25s starting university can book appointments directly with pharmacies. International students are advised to receive their first dose before arriving for their studies.

Wales, Scotland, and Northern Ireland have similar plans, with programs running from July to. Health boards will contact eligible individuals, ensuring widespread access to the vaccine.

Advocacy and Future Considerations

Advocates like Lana Quinlanwho contracted meningitis while studying at Cardiff University, have long called for expanded MenB vaccination programs. Quinlan, who continues to suffer from chronic migraines and memory loss, emphasizes the need for permanent vaccination efforts beyond the current one-off program.

Health Secretary James Murray highlighted the importance of acting swiftly to protect young people at highest risk. “The Kent outbreak and recent clusters indicate a possible change to the way MenB affects people,” Murray stated, urging eligible individuals to get vaccinated to reduce the risk of serious illness and larger outbreaks.

Vaccine experts are assessing the possibility of expanding the routine vaccine program to include older teenagers and young adults. Dr Tom Nutt of charity Meningitis Now welcomed the announcement, noting that while vaccination is the best defense, awareness of meningitis symptoms remains crucial.